| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36c0172f6059c0b200188dba42db7fa6 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P23-00 |
| filingDate |
2010-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_564c6728403ddc5e205219d85a3e7f4c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b851f7580498a74b5619704794da00f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5513acdf4e82198a5f79a80a0c047078 |
| publicationDate |
2012-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-2012005432-A |
| titleOfInvention |
MICROBIAL ENGINEERING FOR THE PRODUCTION OF CHEMICAL AND PHARMACEUTICAL PRODUCTS TO APPEAR FROM THE ISOPRENOID ROUTE. |
| abstract |
The invention relates to the recombinant expression of a taxadiene synthase enzyme and a geranylgeranyl diphosphate (GGPPS) synthase enzyme in cells and to the production of terpenoids. |
| priorityDate |
2010-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |